How should INCI/ingredient names be presented on U.S. skincare labels to avoid common mistakes?

INCI names must match FDA's exact format, listed by descending weight, with no abbreviations or marketing terms.

US buyer view Launch planning Updated: January 28, 2026

Best for

US brand owners, Amazon/FBA sellers, distributors, and private label buyers

Core intent

Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

U.S. skincare labels require INCI names precisely as listed in the International Cosmetic Ingredient Dictionary, with ingredients in descending order of predominance.
Common mistakes include using trade names instead of INCI names, incorrect capitalization, or grouping ingredients.
We verify all labels against the latest FDA database during sampling and provide documentation for compliance.
For US market entry, we recommend starting with 500-unit MOQ for label testing, which adds 7-10 days to sampling timeline.
Our QA team conducts label mock-ups with actual packaging to check for legibility and regulatory alignment before production.

Buyer outcome

A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.

Most common blocker

Missing facility information + inconsistent ingredient/label snapshots across SKUs.

⚠️

This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.